Toggle navigation
TWunroll
TWunroll
faq
Contact US
#MXCT
james lort
LortJames
Maxcyte (MXCT) thoughts heading into 2021. Maxcyte has 2 business and there are near term potential valuation triggers for both. I have no idea whether current price is up with
Read more
Rasmus
Rakapital
Interesting news from $MXCT today, I did not expect them to raise any money before the IPO. Following the trading update and after having spoken to both Doug and Amanda
Read more
HRouge
hareng_rouge
TLDR: headlines like the below may be masking something interesting at ReNeuron - a medical platform businessAs #MXCT and $CLPT show, these sell highDirect NASDAQ comp valued 5x higher#RENE platform
Read more
Simon
zimp_a
Nature reviews/GlobalData har släppt nya siffror för cellterapi-spacet 2020. Vi ser att den enorma pipeplinen fortsätter att växa och antalet aktiva terapier är nu uppe i 1483 st (+47% y/y).
Read more
Rasmus
Rakapital
How to capture the gene- editing and therapy market? In my view, one company offers a unique opportunity to play the immense growth within the field - the American company
Read more
Sahara
saharainvesting
THREAD: Long Maxcyte (MXCT LN)If it ain't broke don't fix it. Maxcyte is another AIM-to-NASDAQ relisting.Exciting area with very little competition, 90% gross margins and 20-30% growth in core business.Would
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree